Showing results (161-170 of 179) with videos related to
Sort By:
Pageof 18
Journal of Medicinal Chemistry|June 9, 2006
A novel series of potent and selective PDE5 inhibitors with potential for high and dose-independent oral bioavailabilityCharlotte M N Allerton, Christopher G Barber, Kevin C Beaumont, et al.Biology|January 10, 2026
Deciphering the Origins of Commercial Sweetpotato Genotypes Using International Genebank DataAlexandre F S Mello, Ronald Robles, Genoveva R M de Simon, et al.Parasites & Vectors|January 28, 2016
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, IndiaMary M Cameron, Alvaro Acosta-Serrano, Caryn Bern, et al.Bioorganic & Medicinal Chemistry|November 22, 2011
The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokineticsDavid J Rawson, Stephen Ballard, Christopher Barber, et al.Bioorganic & Medicinal Chemistry Letters|January 27, 2009
The design and discovery of novel amide CCR5 antagonistsDavid C Pryde, Martin Corless, David R Fenwick, et al.Journal of Medicinal Chemistry|December 7, 2010
An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798)Paul A Stupple, David V Batchelor, Martin Corless, et al.Pediatric Neurology|February 15, 2023
The Spectrum of MORC2-Related Disorders: A Potential Link to Cockayne SyndromeSeth A Stafki, Johnnie Turner, Hannah R Littel, et al.Diagnostic Microbiology and Infectious Disease|March 27, 2010
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance ProgramMichael A Pfaller, Daniel J Diekema, David L Gibbs, et al.Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.Pageof 18